The fact that these T-cell lines respond to MBP [55], similarly to what is observed in MS patients, has raised major questions as to the specificity of the response of CD4+ T-cell lines to myelin antigen in MS patients [56]. The gene discussed is MBP; the disease is myeloid sarcoma.